Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: Drug effects on acetic acid-depressed locomotor activity in ICR mice

Life Sciences

Volumn 85, Issue 7-8, 2009, Pages 309-315

  Stevenson, Glenn W ^a   Cormier, Jim ^a   Mercer, Hannah ^a   Adams, Chloe ^a   Dunbar, Catherine ^a   Negus, S Stevens ^c,d   Bilsky, Edward J ^b  

^a UNIVERSITY OF NEW ENGLAND   (United States)

^b UNIVERSITY OF NEW ENGLAND   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Acetic acid; Locomotor activity; Mice; Morphine; Pain model; Pain depressed behavior; Pain stimulated behavior

Indexed keywords

ACETIC ACID; ANALGESIC AGENT; CAFFEINE; CJ 11974 01; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; MORPHINE; MU OPIATE RECEPTOR AGONIST; NEUROKININ 1 RECEPTOR ANTAGONIST; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADULT ANIMAL; ANALGESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; LOCOMOTION; MALE; MOUSE; NONHUMAN; PAIN; PHARMACOLOGICAL BLOCKING; STIMULATION; WRITHING TEST;

ACETIC ACID; ANALGESIA; ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; BENZENE DERIVATIVES; CAFFEINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; HALOPERIDOL; MALE; MICE; MICE, INBRED ICR; MORPHINE; MOTOR ACTIVITY; PAIN; PAIN MEASUREMENT;

MUS;

EID: 67651151028     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.06.006     Document Type: Article

References (36)

1. American Chronic Pain Association. ACPA Medications & Chronic Pain (2007) Rocklin, CA
2. Bohn L.M., Gainetdinov R.R., Sotnikova T.D., Medvedev I.O., Lefkowitz R.J., Dykstra L.A., and Caron M.G. Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice. Journal of Neuroscience 23 (2003) 10265-10273
3. Brase D.A., Loh H.H., and Way E.L. Comparison of the effects of morphine on locomotor activity, analgesia and primary and protracted physical dependence in six mouse strains. Journal of Pharmacology and Experimental Therapeutics 201 (1977) 368-374
4. Broadbear J.H., Sumpter T.L., Burke T.F., Husbands S.M., Lewis J.W., Woods J.H., and Traynor J.R. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: Comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine. Journal of Pharmacology and Experimental Therapeutics 294 (2000) 933-940
5. Collier H.O., Dinneen L.C., Johnson C.A., and Schneider C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. British Journal of Pharmacology and Chemotherapy 32 (1968) 295-310
6. Dykstra L.A. Effects of buprenorphine on shock titration in squirrel monkeys. Journal of Pharmacology and Experimental Therapeutics 235 (1985) 20-25
7. El Yacoubi M., Ledent C., Menard J.F., Parmentier M., Costentin J., and Vaugeois J.M. The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors. British Journal of Pharmacology 129 (2000) 1465-1473
8. Elmer G.I., Pieper J.O., Levy J., Rubinstein M., Low M.J., Grandy D.K., and Wise R.A. Brain stimulation and morphine reward deficits in dopamine D2 receptor-deficient mice. Psychopharmacology (Berlin) 182 (2005) 33-44
9. Elmer G.I., Pieper J.O., Negus S.S., and Woods J.H. Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests. Pain 75 (1998) 129-140
10. Flecknell P.A. Refinement of animal use-assessment and alleviation of pain and distress. Lab Animal 28 (1994) 222-231
11. Flecknell P.A., Roughan J.V., and Stewart R. Use of oral buprenorphine ('buprenorphine jello') for postoperative analgesia in rats-a clinical trial. Lab Animal 33 (1999) 169-174
12. Hill R. NK1 (substance P) receptor antagonists-why are they not analgesic in humans?. Trends in Pharmacological Sciences 21 (2000) 244-246
13. Hitzemann R., Dains K., Bier-Langing C.M., and Zahniser N.R. On the selection of mice for haloperidol response and non-response. Psychopharmacology (Berlin) 103 (1991) 244-250
14. Kuzmin A., Sandin J., Terenius L., and Ogren S.O. Dose- and time-dependent bimodal effects of kappa-opioid agonists on locomotor activity in mice. Journal of Pharmacology and Experimental Therapeutics 295 (2000) 1031-1042
15. Lazarus H., and Neumann C. Assessing undertreatment of pain: The patients' perspectives. Journal of Pharmaceutical Care in Pain & Symptom Control 9 (2001) 5-34
16. Le Bars D., Gozariu M., and Cadden S.W. Animal models of nociception. Pharmacological Reviews 53 (2001) 597-652
17. Matson D.J., Broom D.C., Carson S.R., Baldassari J., Kehne J., and Cortright D.N. Inflammation-induced reduction of spontaneous activity by adjuvant: A novel model to study the effect of analgesics in rats. Journal of Pharmacology and Experimental Therapeutics 320 (2007) 194-201
18. Meert T.F., and Vermeirsch H.A. A preclinical comparison between different opioids: Antinociceptive versus adverse effects. Pharmacology, Biochemistry and Behavior 80 (2005) 309-326
19. Michael-Titus A., Dourmap N., and Costentin J. Mu and delta opioid receptors control differently the horizontal and vertical components of locomotor activity in mice. Neuropeptides 13 (1989) 235-242
20. Mogil J.S., and Wilson S.G. Nociceptive and morphine antinociceptive sensitivity of 129 and C57BL/6 inbred mouse strains: Implications for transgenic knock-out studies. European Journal of Pain 1 (1997) 293-297
21. Morton D.B., and Griffiths P.H. Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment. Veterinary Record 116 (1985) 431-436
22. Moseley G.L., Zalucki N., Birklein F., Marinus J., van Hilten J.J., and Luomajoki H. Thinking about movement hurts: The effect of motor imagery on pain and swelling in people with chronic arm pain. Arthritis and Rheumatism 59 (2008) 623-631
23. Negus S.S., Vanderah T.W., Brandt M.R., Bilsky E.J., Becerra L., and Borsook D. Preclinical assessment of candidate analgesic drugs: Recent advances and future challenges. Journal of Pharmacology and Experimental Therapeutics 319 (2006) 507-514
24. National Research Council. Guide for the Care and Use of Mammals in Neuroscience and Behavioral Research (2003), National Academy Press, Washington, DC
25. Pearl J., Aceto M.D., and Harris L.S. Prevention of writhing and other effects of narcotics and narcotic antagonists in mice. Journal of Pharmacology and Experimental Therapeutics 160 (1968) 217-230
26. Pereira Do Carmo G, Stevenson GW, Carlezon WA and Negus SS. Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: Further studies on pain-depressed behavior. Pain 144, 170-177, 2009
27. Raehal K.M., Lowery J.J., Bhamidipati C.M., Paolino R.M., Blair J.R., Wang D., Sadee W., and Bilsky E.J. In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice. Journal of Pharmacology and Experimental Therapeutics 313 (2005) 1150-1162
28. Roughan J.V., and Flecknell P.A. Effects of surgery and analgesic administration on spontaneous behaviour in singly housed rats. Research in Veterinary Science 69 (2000) 283-288
29. Stevenson G.W., Bilsky E.J., and Negus S.S. Targeting pain-suppressed behaviors in preclinical assays of pain and analgesia: Effects of morphine on acetic acid-suppressed feeding in C57BL/6 J mice. Journal of Pain 7 (2006) 408-416
30. Takasuna M., Negus S.S., DeCosta B.R., and Woods J.H. Opioid pharmacology of the antinociceptive effects of loperamide in mice. Behavioral Pharmacology 5 (1994) 189-195
31. Teitelbaum H., Giammatteo P., and Mickley G.A. Differential effects of localized lesions of n. accumbens on morphine- and amphetamine-induced locomotor hyperactivity in the C57BL/6J mouse. Journal of Comparative Physiology and Psychology 93 (1979) 745-751
32. Urban L.A., and Fox A.J. NK1 receptor antagonists-Are they really without effect in the pain clinic?. Trends in Pharmacological Sciences 21 (2000) 462-464 author reply 465
33. van Abeelen J.H., and van den Heuvel C.M. Behavioural responses to novelty in two inbred mouse strains after intrahippocampal naloxone and morphine. Behavioural Brain Research 5 (1982) 199-207
34. van Weering M., Vollenbroek-Hutten M.M., Kotte E.M., and Hermens H.J. Daily physical activities of patients with chronic pain or fatigue versus asymptomatic controls. A systematic review. Clinical Rehabilitation 21 (2007) 1007-1023
35. Ward S.J., and Takemori A.E. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice. Journal of Pharmacology and Experimental Therapeutics 224 (1983) 525-530
36. Wigdor S., and Wilcox G.L. Central and systemic morphine-induced antinociception in mice: Contribution of descending serotonergic and noradrenergic pathways. Journal of Pharmacology and Experimental Therapeutics 242 (1987) 90-95